Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma	Active, not recruiting	Phase 1	2026-05-07		NCT05154994

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
University of Utah	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Huntsman Cancer Institute/University of Utah	Salt Lake City	United States	249

Clinical trials